Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...

Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...